Laplace Interventional
Manufacturing · Minnesota, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
12975 16th Ave N Ste 100, Plymouth, Minn...Website
www.laplaceint.comRevenue
$5.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Laplace Interventional
Laplace Interventional Inc. is a medical device company based in Plymouth, MN, specializing in the development of innovative solutions for patients with Tricuspid Regurgitation (TR). The company is working on a Transcatheter tricuspid valve replacement (TTVR) system designed to deliver a prosthetic valve through a minimally invasive procedure, thus improving life expectancy and quality of life for affected patients. The TTVR system is currently investigational and not available for sale in the US or other regions. Laplace Interventional aims to reduce complications associated with traditional open-heart surgery for patients in need of this intervention.Explore more
Laplace Interventional Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Laplace Interventional your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Laplace Interventional has new funding data
Earning: See what the market has to say on Laplace Interventional recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Laplace Interventional, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Laplace Interventional launches new products
Website visits: Recent activity has been detected on your website
Click to see if Laplace Interventional had a recent Job posting/layoffs
Check if Laplace Interventional has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Laplace Interventional
Check out if Laplace Interventional is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Laplace Interventional is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Laplace Interventional is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Laplace Interventional.
Laplace Interventional financials insights
Gather financial insights about Laplace Interventional, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Series B
$12.9M
Laplace Interventional Tech Stack
Laplace Interventional News & Media
Laplace Interventional completes Trans-Jugular US Early Feasibility Study and adds Trans-Femoral approach
Laplace announces two major achievements: successful completion of patient enrollment in its US Early Feasibility Study (EFS)on its Trans-jugular (TJ) system and successful treatment of first two patients with their Trans-femoral (TF) delivery system. PLYMOUTH, Minn., Oct. 24, 2025...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Laplace Interventional
Sign Up For FreeTo access detailed company insights
Laplace Interventional Inc. is a medical device company based in Plymouth, MN, specializing in the development of innovative solutions for patients with Tricuspid Regurgitation (TR). The company is working on a Transcatheter tricuspid valve replacement (TTVR) system designed to deliver a prosthetic valve through a minimally invasive procedure, thus... Read More
